“Let food be thy medicine and medicine be thy food.” -- Hippocrates
The “food as medicine” concept has been around for some time but has gained significant traction recently, as consumers put their health and well-being front and center, especially in the midst of COVID 19. The concept generally refers to the idea of using diet and nutrition to promote overall health and wellness.
In this Food Institute webinar, we invite two leaders in the food as medicine industry -- Viome executives Naveen Jain (CEO) and Momo Vuyisich (Chief Science Officer) -- to share how their company is tackling health-related issues with the latest science behind the gut microbiome.
Find out how Viome is specifically leveraging the science behind gene expression to deliver truly personalized insights, food recommendations, and supplements. The ultimate goal: to help prevent, manage, and even eliminate the effects of some of the world’s most chronic illnesses.
This event will be recorded and sent to all registrants.
This webinar is sponsored by Lazard Middle Market LLC.
Lazard Middle Market LLC, a subsidiary of Lazard Ltd (NYSE: LAZ), provides customized advice on mergers and acquisitions, debt and equity recapitalizations, and financial restructurings to mid-sized companies across a broad range of industries. Our food-dedicated bankers have played key advisory roles in some of the most important, complex, and industry-defining transactions. For more information about our Consumer, Food & Retail Group, please visit https://www.lazard.com/businesses/financial-advisory/middle-market-advisory/consumer-food-retail/.